Cargando…
Outcomes of Bebtelovimab Therapy in Patients With Solid Organ Transplantation With Mild and Moderate COVID-19
Solid organ transplant recipients (SOTRs) are at greater risk of poorer outcomes from coronavirus disease 2019 (COVID-19) as compared to the general population. Because of significant drug-drug interactions between nirmatrelvir-ritonavir and immunosuppressive agents as well as logistical challenges...
Autores principales: | Kapur, Rohan, Okumura, Kenji, Feola, Nicholas, Keller, Marina, Dhand, Abhay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259679/ https://www.ncbi.nlm.nih.gov/pubmed/37313067 http://dx.doi.org/10.7759/cureus.38867 |
Ejemplares similares
-
Outcomes of COVID-19 in Solid Organ Transplants
por: Ranabothu, Saritha, et al.
Publicado: (2020) -
1350. Solid Organ Transplantation From COVID Positive Donors: Trends in Utilization, Discard & Long-term Outcomes in the United States
por: Dhand, Abhay, et al.
Publicado: (2023) -
Early Trends to Show the Efficacy of Cordyceps militaris in Mild to Moderate COVID Inflammation
por: Dubhashi, Siddharth, et al.
Publicado: (2023) -
Letter Regarding “Cardiac Outcomes in Isolated Heart and Simultaneous Kidney and Heart Transplants in the United States”
por: Okumura, Kenji, et al.
Publicado: (2021) -
Bebtelovimab-Induced Bradycardia Leading to Cardiac Arrest
por: Gearges, Christina, et al.
Publicado: (2022)